Prostate cancer drug that can halve death risk to be offered to thousands in England

24 octobre 2025 | Andrew Gregory Health editor
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death. In guidance published on Friday, the National (…)
 Site référencé:  The Guardian

The Guardian 

Posh, proud and impossible to ignore : the incredible life of Annabel Goldsmith
24/10/2025
Ireland votes for next president as polls predict landslide for Catherine Connolly
24/10/2025
‘It’s scary how many St George’s flags there were’ : Blood Orange on coming home to Essex and mourning his mother
24/10/2025
Faceless figures and mysterious music : ghost stories from English Heritage sites
24/10/2025
Plain rice and little else : life for 120,000 refugees inside Mauritania’s vast camp on Mali’s border
24/10/2025
Experience : I’ve been on television more than 2,500 times (but you won’t know my face)
24/10/2025